Nu Skin Enterprises (NYSE:NUS) Given New $6.75 Price Target at Citigroup

Nu Skin Enterprises (NYSE:NUS) had its target price cut by Citigroup from $11.50 to $6.75 in a report published on Tuesday, Benzinga reports. They currently have a neutral rating on the stock.

A number of other research analysts have also recently commented on NUS. DA Davidson reduced their price objective on Nu Skin Enterprises from $12.50 to $11.00 and set a “neutral” rating on the stock in a research note on Monday, August 12th. StockNews.com upgraded shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research note on Friday, September 6th.

Nu Skin Enterprises Stock Performance

NYSE NUS opened at $6.17 on Tuesday. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.12 and a quick ratio of 1.33. Nu Skin Enterprises has a 1-year low of $5.95 and a 1-year high of $20.75. The firm has a market capitalization of $306.40 million, a P/E ratio of -2.07 and a beta of 1.12. The business’s 50-day simple moving average is $7.48 and its 200-day simple moving average is $10.31.

Nu Skin Enterprises (NYSE:NUS) last announced its quarterly earnings results on Thursday, August 8th. The company reported $0.21 earnings per share for the quarter, beating analysts’ consensus estimates of $0.17 by $0.04. Nu Skin Enterprises had a negative net margin of 8.05% and a positive return on equity of 7.80%. The firm had revenue of $439.10 million for the quarter, compared to analysts’ expectations of $431.87 million. During the same period in the previous year, the company posted $0.54 earnings per share. Nu Skin Enterprises’s revenue was down 12.2% compared to the same quarter last year. Equities analysts predict that Nu Skin Enterprises will post 0.78 EPS for the current year.

Nu Skin Enterprises Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, September 11th. Investors of record on Friday, August 30th were paid a $0.06 dividend. This represents a $0.24 annualized dividend and a dividend yield of 3.89%. The ex-dividend date was Friday, August 30th. Nu Skin Enterprises’s dividend payout ratio (DPR) is -8.05%.

Institutional Investors Weigh In On Nu Skin Enterprises

Hedge funds have recently bought and sold shares of the business. Pacer Advisors Inc. purchased a new position in shares of Nu Skin Enterprises during the 2nd quarter valued at approximately $25,230,000. Federated Hermes Inc. boosted its stake in Nu Skin Enterprises by 111.8% during the 2nd quarter. Federated Hermes Inc. now owns 1,323,542 shares of the company’s stock valued at $13,950,000 after acquiring an additional 698,722 shares during the last quarter. Vanguard Group Inc. grew its holdings in Nu Skin Enterprises by 4.4% during the 1st quarter. Vanguard Group Inc. now owns 6,489,580 shares of the company’s stock worth $89,751,000 after acquiring an additional 274,309 shares in the last quarter. Millennium Management LLC increased its position in shares of Nu Skin Enterprises by 100.5% in the 2nd quarter. Millennium Management LLC now owns 534,579 shares of the company’s stock worth $5,634,000 after purchasing an additional 267,965 shares during the last quarter. Finally, Jacobs Levy Equity Management Inc. increased its position in shares of Nu Skin Enterprises by 178.3% in the 1st quarter. Jacobs Levy Equity Management Inc. now owns 283,355 shares of the company’s stock worth $3,919,000 after purchasing an additional 181,528 shares during the last quarter. Institutional investors and hedge funds own 82.84% of the company’s stock.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.